Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:25 PM
Ignite Modification Date:
2025-12-24 @ 3:25 PM
NCT ID:
NCT02142192
Eligibility Criteria:
Key Inclusion Criteria:
* Must have documented diagnosis of RMS at screening.
* Must fall within the therapeutic indications stated in the locally approved label for natalizumab.
* Must have an EDSS score from 0 to 6.5, inclusive.
Key Exclusion Criteria:
* Any prior use of natalizumab.
* Positive for anti-natalizumab antibodies at screening.
* Treatment with immunomodulatory injections (including IFN-β and glatiramer acetate) within 2 weeks prior to Screening.
NOTE: Other protocol defined Inclusion/Exclusion criteria may apply
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02142192
Study Brief:
Protocol Section:
NCT02142192